Clinical Trials on Mycobacterium Tuberculosis, Protection Against in Switzerland

Total 17 results

François Spertini
University of Oxford

Completed

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039) (TB039)

Tuberculosis | Mycobacterium Tuberculosis, Protection Against

Switzerland
University of Zurich

Recruiting

Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy

Tuberculosis Infection

Switzerland
University Children's Hospital Basel
University Hospital, Geneva; University Hospital Inselspital, Berne; Kantonsspital... and other collaborators

Recruiting

Diagnosis of Tuberculosis in Swiss Children (CITRUS)

Tuberculosis | Mycobacterium Tuberculosis

Switzerland
University Hospital, Basel, Switzerland
Fachhochschule Nordwestschweiz

Withdrawn

miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB)

Active Tuberculosis

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area

Tuberculosis | Latent Tuberculosis Infection

Switzerland
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults

Tuberculosis (TB)

Switzerland
Ligue Pulmonaire Genevoise

Completed

Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients

Latent Tuberculosis Infection

Switzerland
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

Tuberculosis

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Results of an Interferon-Gamma Release Assay After Treatment for Tuberculosis

Tuberculosis

Switzerland
Innovative Medicines for Tuberculosis
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing

Tuberculosis, Pulmonary

Switzerland
University Hospital, Basel, Switzerland

Completed

Diagnosing of Acute Tuberculosis (SwEaTB)

Tuberculosis

Switzerland
Innovative Medicines for Tuberculosis
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation

Tuberculosis | Tuberculosis, Pulmonary

Switzerland
Aeras
Sanofi Pasteur, a Sanofi Company

Completed

A Study for Safety and Immunogenicity of BCG and AERAS-404 in HIV-Negative, TB-Negative, BCG-Naive Adults (C-013-404)

Tuberculosis

Switzerland
Biofabri, S.L
Centre Hospitalier Universitaire Vaudois; TuBerculosis Vaccine Initiative; Universidad...

Completed

Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine. (MTBVAC)

Healthy | Tuberculosis

Switzerland
University Hospital, Geneva
Ligue Pulmonaire Genevoise

Completed

Detection of Latent Tuberculosis in Hemodialysis Patients

Chronic Renal Failure

Switzerland
Tuberculosis Network European Trialsgroup

Completed

T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals (TBNET-TIPS)

Tuberculosis | Monitoring, Immunologic

Denmark, United Kingdom, Sweden, Australia, Bulgaria, Germany, Greece, Italy, Netherlands, Portugal, Romania, Spain, Switzerland, Turkey
University Hospital, Basel, Switzerland
Swiss Tropical & Public Health Institute; Ifakara Health Institute

Completed

Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa (RenalOne)

HIV Infections | Hypertension | Diabetes Mellitus | Chronic Kidney Diseases | Tuberculosis | Schistosomiasis

Switzerland

Clinical Trials on Mycobacterium Tuberculosis, Protection Against in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations